SCHEMBL4617455

SCHEMBL4617455

Cc1cc(C)c(S(=O)(=O)c2ccccc2)cc1S(=O)(=O)NCCC1CCOCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 2/20 0.46
BRD4 O60885 1/20 0.44
PIK3CD O00329 1/20 0.42
PIK3CB P42338 1/20 0.42
PIK3CG P48736 1/20 0.42
ALDH1A1 P00352 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
TSHR P16473 1/20 0.39
KDM1A O60341 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
PKM P14618 1/20 0.37
NPC1 O15118 1/20 0.37
CNR2 P34972 1/20 0.37
GBA1 P04062 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6101464 0.89 PIK3CD (0.43) SFRP1BRD4PIK3CDPIK3CBPIK3CG
SCHEMBL4618055 0.89 GBA1 (0.50) SFRP1ALDH1A1L3MBTL1TSHRSMN1; SMN2
SCHEMBL4618967 0.88 SFRP1 (0.61) SFRP1BRD4PIK3CDPIK3CBPIK3CG
SCHEMBL4618493 0.85 SFRP1 (0.47) SFRP1BRD4PIK3CDPIK3CBPIK3CG
SCHEMBL6101011 0.84 BRD4 (0.42) SFRP1BRD4PIK3CDPIK3CBPIK3CG
SCHEMBL6102480 0.81 SFRP1 (0.59) SFRP1BRD4PIK3CDPIK3CBPIK3CG
SCHEMBL17205770 0.80 GBA1 (0.55) BRD4ALDH1A1TSHRKDM1AMAOA
SCHEMBL6101893 0.80 HTT (0.44) SFRP1BRD4ALDH1A1L3MBTL1TSHR
SCHEMBL4617527 0.78 SFRP1 (0.49) SFRP1BRD4PIK3CDPIK3CBPIK3CG
SCHEMBL4617958 0.78 SFRP1 (0.51) SFRP1BRD4PIK3CDPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 SFRP1 1/4885BRD4 2225/4885PIK3CD 3716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.